Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-08-26
1994-11-22
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 46, 514 45, 536 2713, A61K 3170
Patent
active
053669606
ABSTRACT:
The present invention discloses the use of [R]-3-(2-deoxy-.beta.-D-erythropentofuranosyl)-3,6,7,8-tetrahydroimidazo-[ 4,5-d][1,3]diazepin-8-ol, also commonly known as pentostatin, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprised of such compounds, in the prophylactic or affirmative treatment of cerebral and cardiovascular disorders such as cerebral and myocardial ischemia. The invention also discloses the administration of pentostatin along with adenosine in the prophylactic or affirmative treatment of cerebral and cardiovascular disorders.
REFERENCES:
patent: 4151347 (1979-04-01), Umezawa et al.
patent: 4364922 (1982-12-01), Berne et al.
patent: 4575498 (1986-03-01), Holmes et al.
patent: 4673563 (1987-06-01), Berne et al.
patent: 4713372 (1987-12-01), Schaumberg et al.
patent: 4912092 (1990-03-01), Gruber
patent: 4935505 (1990-06-01), Townsend et al.
patent: 5104859 (1992-04-01), Sollevi
patent: 5231086 (1993-07-01), Sollevi
Takahashi, "Albuminuria Improving Drug Contains 2'-Deoxy-coformycin", Japanese Patent document SN 2,062,891, Mar. 2, 1990; Derwent Abstract, 90-111969/15; only Abstract provided.
Boehringer Mannheim GmbH, "Imidazole-Ribosylcyclophosphates-(AICAR-3':5'-Cyclo-or-Monophosphates) with Antilipolytic Activity", W. German Patent document SN 2,026,040, Dec. 9, 1971; Derwent Abstract, 79007S-B; only Abstract supplied.
Swain et al., "Accelerated Repletion of ATP and GTP Pools in Postischemic Canine Myocardium Using a Precursor of Purine de Novo Synthesis", Circulation, 51(1), 102-105 (1982).
Mitsos et al., "Protective Effects of AICAriboside in the Globally Ischemic Isolated Car Heart", Pharmacology, 31, 121-131 (1985).
Bolling et al., "Augmenting Intracellular Adenosine Improves Myocardial Recovery", J. Thorac. Cardiovasc. Surg., 99, 469-474 (1990).
Fukunaga et al., "Hypotensive Effects of Adenosine and Adenosine Triphosphate Compared with Sodium Nitroprusside", Anesthesia and Analgesia, 61(3), 273-278 (1982).
Hall et al., "Antiviral Drug and Interferon Combinations", Ch.3 in Antiviral Agents: The Development and Assessment of Antiviral Chemotherapy, vol. II, CRC Press, Boca Raton, Fla., 1987, pp. 29-43 and 74-77, note particularly Fig. 6 on p. 42.
Berkow et al. (eds.), The Merck Manual of Diagnosis and Therapy, 16th Ed., Merck Res. Labs., Rahway, N.J., 1992, see pp. 1450-1457.
Drury et al., "The Physiological Activity of Adenine Compounds with Especial Reference to Their Action Upon the Mammalian Heart", J. Physiology (Cambridge), 68, 213-237 (1929).
Dawicki et al. (I), "Potentiation of the Antiplatelet Action of Adenosine in Whole Blood by Dipyridamole or Dilazep and the cAMP Phosphodiesterase Inhibitor, RA 233", Thromb. Res., 43(2), 161-175 (1986); Chem. Abstr., 105(7), p. 44, Abstr. No. 54382f (1984); only Abstract provided.
Goday et al., "Importance of Platelet-free Preparations for Evaluating Lymphocyte Nucleotide Levels in Inherited or Acquired Immunodeficiency Syndromes", Clin. Sci., 65(6), 635-643 (1983); Chem. Abstr., 100(1), p. 264, Abstr. No. 3045n (1984); only Abstract provided.
Hostetter et al., "The Erythrocyte as Instigator of Inflammation, Generation of Amidated C3 by Erythrocyte Adenosine Deaminase", J. Clin. Invest., 84, 665-671 (1989).
Dawicki et al.(II), "Role of Adenosine Uptake and Metabolism by Blood Cells in the Antiplatelet Actions of Dipyridamole, Dilazep and Nitrobenzylthioinosine", Biochemical Pharmacology, 34(22), 3965-3972 (1985).
Masters et al., "Platelet Anti-aggregating and Hemodynamic Effects of Adenosine and Prostaglandin E.sub.1 ", Thorac. Cardiovasc. Surgeon, 30, 14-20 (1982).
Ashbrook Charles W.
Atkins Michael J.
Crane L. Eric
Rollins John W.
Warner-Lambert & Company
LandOfFree
Method of treating cerebral and cardiovascular disorders employi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating cerebral and cardiovascular disorders employi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cerebral and cardiovascular disorders employi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991515